berberine has been researched along with Pneumonia, Viral in 3 studies
Pneumonia, Viral: Inflammation of the lung parenchyma that is caused by a viral infection.
Excerpt | Relevance | Reference |
---|---|---|
"Viral pneumonia is a common complication caused by Influenza A virus infection and is characterized by severe pulmonary inflammation." | 1.72 | Berberine ameliorates pulmonary inflammation in mice with influenza viral pneumonia by inhibiting NLRP3 inflammasome activation and gasdermin D-mediated pyroptosis. ( An, C; Dong, R; Ge, D; Hao, Y; Liu, H; Wu, J; Wu, Y; You, L; Zhou, S, 2022) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 3 (100.00) | 2.80 |
Authors | Studies |
---|---|
An, C | 1 |
Wu, Y | 1 |
Wu, J | 1 |
Liu, H | 1 |
Zhou, S | 1 |
Ge, D | 1 |
Dong, R | 1 |
You, L | 1 |
Hao, Y | 1 |
Pizzorno, A | 1 |
Padey, B | 1 |
Dubois, J | 1 |
Julien, T | 1 |
Traversier, A | 1 |
Dulière, V | 1 |
Brun, P | 1 |
Lina, B | 1 |
Rosa-Calatrava, M | 1 |
Terrier, O | 1 |
Fan, TT | 1 |
Cheng, BL | 1 |
Fang, XM | 1 |
Chen, YC | 1 |
Su, F | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Remdesivir Versus Remdesivir- Ivermectin Combination Therapy in Severe and Critically Ill Covid-19[NCT04944082] | Phase 4 | 60 participants (Anticipated) | Interventional | 2021-07-01 | Not yet recruiting | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 review available for berberine and Pneumonia, Viral
Article | Year |
---|---|
Application of Chinese Medicine in the Management of Critical Conditions: A Review on Sepsis.
Topics: Anti-Inflammatory Agents; Artemisinins; Astragalus propinquus; Berberine; Betacoronavirus; Coronavir | 2020 |
2 other studies available for berberine and Pneumonia, Viral
Article | Year |
---|---|
Berberine ameliorates pulmonary inflammation in mice with influenza viral pneumonia by inhibiting NLRP3 inflammasome activation and gasdermin D-mediated pyroptosis.
Topics: Animals; Berberine; Inflammasomes; Influenza A Virus, H1N1 Subtype; Mice; NLR Family, Pyrin Domain-C | 2022 |
In vitro evaluation of antiviral activity of single and combined repurposable drugs against SARS-CoV-2.
Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Berberine; Betacoronavirus; Chlorocebus | 2020 |